Pharmacological exposure to ribavirin: a key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment.

MLA

Loustaud-Ratti, Véronique, et al. “Pharmacological Exposure to Ribavirin: A Key Player in the Complex Network of Factors Implicated in Virological Response and Anaemia in Hepatitis C Treatment.” Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, vol. 43, no. 11, Nov. 2011, pp. 850–55. EBSCOhost, https://doi.org/10.1016/j.dld.2011.04.002.

APA

Loustaud-Ratti, V., Carrier, P., Rousseau, A., Maynard, M., Babany, G., Alain, S., Trépo, C., De Ledinghen, V., Bourlière, M., Pol, S., Di Martino, V., Zarski, J.-P., Pinta, A., Sautereau, D., & Marquet, P. (2011). Pharmacological exposure to ribavirin: a key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 43(11), 850–855. https://doi.org/10.1016/j.dld.2011.04.002

Chicago

Loustaud-Ratti, Véronique, Paul Carrier, Annick Rousseau, Marianne Maynard, Gérard Babany, Sophie Alain, Christian Trépo, et al. 2011. “Pharmacological Exposure to Ribavirin: A Key Player in the Complex Network of Factors Implicated in Virological Response and Anaemia in Hepatitis C Treatment.” Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 43 (11): 850–55. doi:10.1016/j.dld.2011.04.002.